These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34666312)

  • 21. Familial colorectal cancer.
    Lung MS; Trainer AH; Campbell I; Lipton L
    Intern Med J; 2015 May; 45(5):482-91. PubMed ID: 25955461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer surveillance behaviors among members of typical and attenuated FAP families.
    Kinney AY; Hicken B; Simonsen SE; Venne V; Lowstuter K; Balzotti J; Burt RW
    Am J Gastroenterol; 2007 Jan; 102(1):153-62. PubMed ID: 17266693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.
    Septer S; Lawson CE; Anant S; Attard T
    Fam Cancer; 2016 Jul; 15(3):477-85. PubMed ID: 27056662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome.
    Möslein G; Pistorius S; Saeger HD; Schackert HK
    Langenbecks Arch Surg; 2003 Mar; 388(1):9-16. PubMed ID: 12690475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes.
    Cruz-Correa M; Diaz-Algorri Y; Mendez V; Vazquez PJ; Lozada ME; Freyre K; Lathroum L; Gonzalez-Pons M; Hernandez-Marrero J; Giardiello F; Rodriguez-Quilichini S
    Fam Cancer; 2013 Sep; 12(3):555-62. PubMed ID: 23460355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome.
    Al-Sukhni W; Aronson M; Gallinger S
    Surg Clin North Am; 2008 Aug; 88(4):819-44, vii. PubMed ID: 18672142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary colorectal cancer syndromes: an overview.
    Kwak EL; Chung DC
    Clin Colorectal Cancer; 2007 Jan; 6(5):340-4. PubMed ID: 17311698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
    Soravia C; Bapat B; Cohen Z
    Schweiz Med Wochenschr; 1997 Apr; 127(16):682-90. PubMed ID: 9140167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hereditary colorectal cancer associated with polyposis syndromes].
    Soravia C; Pocard M
    Ann Chir; 1999; 53(10):979-84. PubMed ID: 10670145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Familial Adenomatous Polyposis in Children and Adolescents: Position Paper From the ESPGHAN Polyposis Working Group.
    Hyer W; Cohen S; Attard T; Vila-Miravet V; Pienar C; Auth M; Septer S; Hawkins J; Durno C; Latchford A
    J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):428-441. PubMed ID: 30585891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics, clinical manifestations and management of FAP and HNPCC.
    Pavlovic-Calic N; Muminhodzic K; Zildzic M; Smajic M; Gegic A; Alibegovic E; Salkic N; Jovanovic P; Basic M; Iljazovic S
    Med Arh; 2007; 61(4):256-9. PubMed ID: 18298004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of hereditary colorectal cancer.
    Jo WS; Chung DC
    Semin Oncol; 2005 Feb; 32(1):11-23. PubMed ID: 15726502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprevention Considerations in Patients with Hereditary Colorectal Cancer Syndromes.
    Macaron C; Mankaney GN; Haider M; Mouchli M; Hurley K; Burke CA
    Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):131-146. PubMed ID: 34798982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene tests and counseling for colorectal cancer risk: lessons from familial polyposis.
    Petersen GM; Boyd PA
    J Natl Cancer Inst Monogr; 1995; (17):67-71. PubMed ID: 8573458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revolutionary advances in the diagnosis and treatment of Familial Adenomatous Polyposis.
    Edlich R; Cross CL; Wack CA; Chase ME; Gubler K; Long WB
    J Environ Pathol Toxicol Oncol; 2009; 28(1):47-52. PubMed ID: 19392654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Familial adenomatous polyposis].
    Constanda MT; Munier FL; Caplin S; Givel JC
    Praxis (Bern 1994); 1996 Aug; 85(35):1052-7. PubMed ID: 8848677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotype and management of patients with familial adenomatous polyposis in Hong Kong: perspective of the Hereditary Gastrointestinal Cancer Registry.
    Ho JW; Chu KM; Tse CW; Yuen ST
    Hong Kong Med J; 2002 Oct; 8(5):342-7. PubMed ID: 12376711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
    Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
    Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal adenomatous polyposis syndromes: Genetic determinism, clinical presentation and recommendations for care.
    Buecher B
    Bull Cancer; 2016 Feb; 103(2):199-209. PubMed ID: 26805944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.